We are monitoring the impact of COVID-19 on Europe Biochips Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1552
Share on
Share on

Europe Biochips Market Research Report - Segmented By Type, End User & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1552
Pages: 133

Europe Biochips Market Size (2021 to 2026)

The size of the Europe Biochips Market was worth USD 3.49 billion in 2021 and predicted to expand at a CAGR of 21.94% from 2021 to 2026. This value is forecasted to grow USD 9.40 billion by 2026.

Europe is positioned second in leading the dominant shares of the global biochips market in 2019. The rising demand for personalized medicine is significant, propelling the growth of the market. Key player’s presence in this region, which is innovating the technology of drug development with the help of biochips, is another crucial factor favoring the market growth. The governments in different countries in Europe are funding the development of biochips technology. The European Union is also promoting biochips in research like the NABIS (Nanobiotechnology with self-organizing structures), a European Union-funded project. The biochips are also used to trace biological warfare and also used in forensic. 

The availability of alternate methods in this region is restricting the market growth to some extent. In addition, the cost of biochips is high, and the standardization of biochips is further hindering the growth of the biochips market. 

This research report on the European biochips market has been segmented and sub-segmented into the following categories.

  • DNA Chips
    • SNP Genotyping
    • Genomics
    • Agricultural Biotechnology
    • Gene Expression
    • Cancer Diagnosis & Treatment
    • Drug Discovery
    • Others
  • Lab-On-A-Chip
    • Clinical Diagnostics
    • IVD & POC
    • Drug Discovery
    • Genomics
    • Proteomics
  • Protein Chips
    • Expression Profiling
    • High-Throughput Screening
    • Proteomics
    • Diagnostics
    • Drug Discovery

By End User: 

  • Hospitals and Diagnostic Centers
  • Biotechnology and Pharmaceutical Companies
  • Academic & Research Institutes

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Based on the region, the European region accounted for 28% of the global market share and is forecasted to register a promising CAGR during the forecast period due to various reasons such as easy access to the latest technologies, a large patient pool, and promising government policies.

The UK biochips market had occupied the majority of the European market in 2019. The Department for Environment Food and Rural Affairs (Defra) is funding the pan viral microarray, which detects 1132 different viruses from 40 viral families in a single test using biochips. In addition, the various institutes in the country are using biochips for the study of different biomolecules.

However, the German biochips market is predicted to grow at the fastest growth rate during the forecast period. This is because Germany has a strong key player’s presence, significantly favoring the market growth. They have developed a fingernail-sized DNA chip in Germany that can analyze thousands of genes in a tiny sample.

KEY MARKET PLAYERS:

Companies playing a prominent role in the European biochips market profiled in the report are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 DNA Chips

                                                5.1.2.1 SNP Genotyping

                                                5.1.2.2 Genomics

                                                5.1.2.3 Agricultural Biotechnology

                                                5.1.2.4 Gene Expression

                                                5.1.2.5 Cancer Diagnosis & Treatment

                                                5.1.2.6 Drug Discovery

                                                5.1.2.7 Others

                                5.1.3 Lab-On-A-Chip      

                                                5.1.3.1 Clinical Diagnostics

                                                5.1.3.2 IVD & POC

                                                5.1.3.3 Drug Discovery

                                                5.1.3.4 Genomics

                                                5.1.3.5 Proteomics

                                5.1.4 Protein Chips         

                                                5.1.4.1 Expression Profiling

                                                5.1.4.2 High-Throughput Screening

                                                5.1.4.3 Proteomics

                                                5.1.4.4 Diagnostics

                                                5.1.4.5 Drug Discovery

                                5.1.5 Other types            

                                5.1.6 Y-o-Y Growth Analysis, By Type      

                                5.1.7 Market Attractiveness Analysis, By Type     

                                5.1.8 Market Share Analysis, By Type      

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals and Diagnostics Centers

                                5.2.3 Biotechnology and Pharmaceutical Companies       

                                5.2.4 Academic & Research Institutes    

                                5.2.5 Y-o-Y Growth Analysis, By End User              

                                5.2.6 Market Attractiveness Analysis, By End User            

                                5.2.7 Market Share Analysis, By End User              

                5.3 Fabrication Technology                         

                                5.3.1 Introduction           

                                5.3.2 Microfluidics          

                                5.3.3 Microarrays            

                                5.3.4 Y-o-Y Growth Analysis, By Fabrication Technology

                                5.3.5 Market Attractiveness Analysis, By Fabrication Technology                

                                5.3.6 Market Share Analysis, By Fabrication Technology

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Fabrication Technology

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Fabrication Technology

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Fabrication Technology

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Athersys                      

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                  

                8.6 Aastrom Biosciences                               

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Biochips Market, By Region, From 2021 to 2026 (USD Million)
  2. Europe Biochips Market, By Type, From 2021 to 2026 (USD Million)
  3. Europe DNA Chips Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  5. Europe SNP Genotyping Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Genomics Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Agricultural Biotechnology Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Gene Expression Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Cancer Diagnosis & Treatment Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Other DNA chips Market, By Region, From 2021 to 2026 (USD Million)
  12. Europe Lab-On-A-Chip Market, By Region, From 2021 to 2026 (USD Million)
  13. Europe Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  14. Europe Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe IVD & POC Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Genomics Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  19. Europe Protein Chips Market, By Region, From 2021 to 2026 (USD Million)
  20. Europe Other types Market, By Region, From 2021 to 2026 (USD Million)
  21. Europe Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  22. Europe Expression Profiling Market, By Region, From 2021 to 2026 (USD Million)
  23. Europe High-Throughput Screening Market, By Region, From 2021 to 2026 (USD Million)
  24. Europe Proteomics Market, By Region, From 2021 to 2026 (USD Million)
  25. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  26. Europe Drug Discovery Market, By Region, From 2021 to 2026 (USD Million)
  27. Europe Biochips Market, By End User , From 2021 to 2026 (USD Million)
  28. Europe Hospitals and Diagnostics Centers Market, By Region, From 2021 to 2026 (USD Million)
  29. Europe Biotechnology and Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  30. Europe Academic & Research Institutes Market, By Region, From 2021 to 2026 (USD Million)
  31. Europe Biochips Market, By Fabrication Technology , From 2021 to 2026 (USD Million)
  32. Europe Microfluidics Market, By Region, From 2021 to 2026 (USD Million)
  33. Europe Microarrays Market, By Region, From 2021 to 2026 (USD Million)
  34. U.K Biochips Market, By Type, From 2021 to 2026 (USD Million)
  35. U.K Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  36. U.K Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  37. U.K Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  38. U.K Biochips Market, By End User , From 2021 to 2026 (USD Million)
  39. U.K Biochips Market, By Fabrication Technology , From 2021 to 2026 (USD Million)
  40. Spain Biochips Market, By Type, From 2021 to 2026 (USD Million)
  41. Spain Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  42. Spain Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  43. Spain Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  44. Spain Biochips Market, By End User , From 2021 to 2026 (USD Million)
  45. Spain Biochips Market, By Fabrication Technology , From 2021 to 2026 (USD Million)
  46. Germany Biochips Market, By Type, From 2021 to 2026 (USD Million)
  47. Germany Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  48. Germany Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  49. Germany Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  50. Germany Biochips Market, By End User , From 2021 to 2026 (USD Million)
  51. Germany Biochips Market, By Fabrication Technology , From 2021 to 2026 (USD Million)
  52. Italy Biochips Market, By Type, From 2021 to 2026 (USD Million)
  53. Italy Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  54. Italy Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  55. Italy Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  56. Italy Biochips Market, By End User , From 2021 to 2026 (USD Million)
  57. Italy Biochips Market, By Fabrication Technology , From 2021 to 2026 (USD Million)
  58. France Biochips Market, By Type, From 2021 to 2026 (USD Million)
  59. France Biochips Market, By DNA Chips, From 2021 to 2026 (USD Million)
  60. France Biochips Market, By Lab-On-A-Chip, From 2021 to 2026 (USD Million)
  61. France Biochips Market, By Protein Chips, From 2021 to 2026 (USD Million)
  62. France Biochips Market, By End User, From 2021 to 2026 (USD Million)
  63. France Biochips Market, By Fabrication Technology, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample